Overactive Bladder - Results from #260

Update on Overactive Bladder Therapeutic Options. May 14, 2023

Identifying Patient-Centered Research Priorities in Overactive Bladder by Crowdsourcing and Targeted Recruitment. May 7, 2023

Mirabegron versus vibegron in previously untreated female patients with overactive bladder: A randomized, single-clinic, open-label trial. May 7, 2023

Differences between brain responses to peroneal electrical transcutaneous neuromodulation and transcutaneous tibial nerve stimulation, two treatments for overactive bladder. May 7, 2023

A treatment prediction strategy for overactive bladder using a machine learning algorithm that utilized data from the FAITH study. May 7, 2023

Study design of a phase 4, real-world study (COMPOSUR) to evaluate vibegron in patients with overactive bladder. April 30, 2023

Real-time changes in brain activity during tibial nerve stimulation for overactive bladder: Evidence from functional near-infrared spectroscopy hype scanning. April 30, 2023

Predicting Mirabegron Treatment Response in Patients with Overactive Bladder: A Post Hoc Analysis of Data from Clinical Trials. April 30, 2023

Lower Urinary Tract Symptoms and Overactive Bladder in a Large Cohort of Older Poles-A Representative Tele-Survey. April 30, 2023

Updates of Overactive Bladder in Pediatrics. April 23, 2023

Efficacy of acupoint application in patients with overactive bladder: A randomized, placebo-controlled pilot trial. April 23, 2023

Transcutaneous tibial nerve electrical stimulation versus vaginal electrical stimulation in women with overactive bladder syndrome: Is there a role for short-term interventions? April 16, 2023

STOMp: sexual function trial of overactive bladder medication. April 16, 2023

Intradetrusor OnabotulinumtoxinA injections at the time of Holmium Laser Enucleation of the Prostate (HoLEP) for men with overactive bladder symptoms. April 16, 2023

Effectiveness of Fluid and Caffeine Modifications on Symptoms in Adults With Overactive Bladder: A Systematic Review. April 9, 2023

Five-year Results from the Prospective, Multicenter, Observational SOUNDS Study of Patients with Overactive Bladder Treated with the InterStim System for Sacral Neuromodulation. April 9, 2023

Comparison of micro-radiofrequency therapy and tolterodine for the treatment of newly diagnosed overactive bladder: A retrospective cohort study. April 9, 2023

Effect duration of the initial course of peroneal electrical Transcutaneous NeuroModulation in patients with overactive bladder. April 9, 2023

Personalised 3D-Printed Mucoadhesive Gastroretentive Hydrophilic Matrices for Managing Overactive Bladder (OAB). April 2, 2023

Anxiety and depression in association with lower urinary tract symptoms: results from the COBaLT study. April 2, 2023

Page 14 of 122